Printer Friendly

Fibromyalgia's new foe: high-tech medical device shows increasing efficacy for the debilitating symptoms of FMS.

Fibromyalgia patients worldwide are seeing rapid improvement in their symptoms from a high-tech medical device indicated for depression, anxiety, insomnia, and pain.

The device employs two distinct technologies, Microcurrent Electrotherapy Technology (MET) and Cranial Electrotherapy Stimulation (CES), to treat psychological and physical symptoms. It has been used by professional sports teams, such as the Dallas Cowboys and Indiana Pacers, and by pain specialists to treat pain disorders successfully. Recently, rheumatologists have begun prescribing it for their fibromyalgia patients who are reporting significant results.

"The results are so positive in such a difficult-to-treat population that one becomes skeptical," says Robert S. Katz, MD, of Chicago, Illinois, while responding to a study on the device. "However, it is hard to dispute the present data. [Ninety percent] of the patients treated with the CES reported improvement in quality of life." While the degree of improvement varies for each patient, some patients are seeing life-changing results.

Joellen Cross, a patient with chronic fibromyalgia, saw almost a complete turnaround rather quickly. "I received my unit last July and went from despondent and weary from the chronic pain to nearly pain-free and elated at the change, in less than a week," she says. "And the depression I was experiencing more and more as the chronic pain progressed is all but eliminated."

Fibromyalgia is seen in about three to six percent of the population, and there are few effective treatments available. Given that many fibromyalgia patients cannot tolerate medication, this device is seen as a welcome, non-drug approach by patients and physicians to treat its symptoms.

Marilyn Lins, MD, of Utica Neurological Surgery, Inc. in Tulsa, Oklahoma said that the results she has been obtaining have been close to miraculous. A pain specialist, Dr. Lins reported on several fibromyalgia patients who have had sufficient pain relief to resume normal activities with as little as two 20-minute treatments per week. One of her patients stopped limping after only one treatment. Dr. Lins said, "CES has forever changed my treatment approach. I have never experienced results like I have had in the past two months."

"Some rheumatology practices are writing orders for these devices for their entire fibromyalgia caseloads," said Karl Moeller, President and CEO of Moeller Medical, LLC, distributor of the device. "Our goal is to have every fibromyalgia patient try our treatment. Most will benefit to some degree, and some will have dramatic improvement."

Moeller Medical has set up two informational websites for patients and physicians to learn about the device (www.depressiontreatmentnow.com and www.anxietytreatmentnow.com) and plans to follow up with informative sites later this year for insomnia and chronic pain.

About Moeller Medical, Inc.

Moeller Medical, LLC is a privately held company based in Cincinnati, Ohio. Moeller Medical is dedicated to bringing safe, quality health care products to the patient and medical community and is proud to offer a completely non-invasive drug-free form of psychological and pain treatment. For more information, visit http://www.depressiontreatmentnow.com or http://www.anxietytreatmentnow.com. For more information, contact Karl Moeller, President and CEO Moeller Medical, LLC, 513-297-4975, ext. 101.
COPYRIGHT 2008 The Townsend Letter Group
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2008 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Title Annotation:Fibromyalgia syndrome
Publication:Townsend Letter
Geographic Code:1USA
Date:Feb 1, 2008
Words:513
Previous Article:Eat chocolate, drink wine, add fun to your life: noted geriatrician shares secrets of staying young--new book packs practical strategies to live...
Next Article:Longevity news and review.
Topics:

Terms of use | Privacy policy | Copyright © 2019 Farlex, Inc. | Feedback | For webmasters